Drug elimination ( metabolism, excretion) Anton Kohút.

Slides:



Advertisements
Similar presentations
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Advertisements

Drug Fate. Removing substances from the body Some substances are very difficult to eliminate – heavy metals such as lead and mercury The body very efficient.
ADME/T(ox) Absorption Distribution Metabolism Excretion Toxicology.
DRUG EXCRETION. The process by which drugs or metabolites are irreversibly transferred from internal to external environment through renal or non renal.
Pharmacokinetics -- part 1 --
Chapter 2. Metabolism and Elimination A. Liver is the primary site of drug metabolism. First pass effect (or first pass metabolism) : metabolism of a drug.
Absorption/Distribution Drug effects are affected by Absorption and Distribution –Absorption refers to the entrance of drug into the blood stream –Distribution.
Asmah Nasser, M.D. Pharmacokinetics.
Drug Handling in kidney and liver disease
Practical Pharmacokinetics
Drug metabolism and elimination Metabolism  The metabolism of drugs and into more hydrophilic metabolites is essential for the elimination of these.
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Pharmacokinetics: Asmah Nasser, M.D..
Drug Disposition Porofessor Hanan hager Dr.Abdul latif Mahesar College of medicine King Saud University.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
LONGITUDNAL SECTION OF KIDNEY KLECOP, Nipani.
Prof. Hanan Hagar Dr.Abdul latif Mahesar Pharmacology Department Pharmacokinetics III Concepts of Drug Disposition.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Quantitative Pharmacokinetics
Biotransformation and metabolism
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
PHARMACOKINETICS.
PHARMACOKINETICS DR NARENDRA KUMAR.
Renal Excretion of Drugs
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Pharmacology Department
Renal Excretion of Drugs Prof. Hanan Hagar Pharmacology Department.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
CHLORAMPHENICOL First broad spectrum antibiotic. First broad spectrum antibiotic. Originally isolated in Originally isolated in Now produced.
PHARMACOKINETICS Part 3.
Prof. Hanan Hagar Dr.Abdul latif Mahesar Pharmacology Department.
Prof. Hanan Hagar Pharmacology Department By the end of this lecture, students should:  Recognize the importance of biotransformation  Know the different.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Pharmacology Department
TDM Therapeutic Drug Monitoring
Concepts of drug disposition Pharmacology Department
Dr. Muslim Suardi, MSi., Apt.
INTRODUCTION Lecture 2.
Principles of Drug Action
PHARMACOLOGY INTRODUCTION
Pharmacokinetics 2 General Pharmacology M212
Pharmacology I BMS 242 Lecture 4 Pharmacokienetic Principles (3&4): Drug Metabolism and Excretion [Elimination] Dr. Aya M. Serry 2016.
Foundation Knowledge and Skills
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
CHAPTER 4 L. VanValkenburg, RVT, BAS Pharmacokinetics.
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
Renal Excretion of Drugs Pharmacology Department
Basic Principles: PK By: Alaina Darby.
Chapter 3 PHARMACOKINETICS “What the body does to the drug” Lei Wang
ISHIK UNIVERSITY FACULTY OF DENTISTRY
Excretion of drugs.
Chapter 6 EXCRETION OF DRUGS
By: Dr. Roshini Murugupillai
Drug Metabolism Drugs are most often eliminated by biotransformation and/or excretion into the urine or bile. The process of metabolism transforms lipophilic.
Drug Elimination Drug elimination consists of 2 processes
Pharmacokinetics: Metabolism of Drugs
Pharmacokinetics and Factors of Individual Variation
Clinical Pharmacokinetics
Hawler Medical University
Biopharmaceutics Chapter-6
SIVANAGESWARARAO MEKALA
Introduction to Pharmacology
BIOAVAILABILITY.
Drug Metabolism.
Presentation transcript:

Drug elimination ( metabolism, excretion) Anton Kohút

DRUG METABOLISM major site of drug metabolism – liver, exceptions: - suxamethonium and procaine - plasma cholinesterase - tyramine - intestinal wall

Phase 1 Phase 1 - lipophilic molecules are converted into more polar molecules Reactions are catalyzed by the cytochrome P-450 (CYP) by:  oxidation  reduction  reduction  hydrolysis  hydrolysis - products are often less eactive than the parent compounds - after metabolism may be excreted by kidneys - each of the enzyme has a low specificity Phase 2 consists of conjugation reactions Most often involved groups in conjugation are:  glucuronyl  sulphate  methyl  acetyl  glycyl  glutamyl

The two phases of drug metabolism

Metabolism of imipramine

Involvement of some isoform of CYP in the metabolism

FACTORS INFLUENCING DRUG METABOLISM - systemic pathological processes - liver diseases, heart failure - systemic pathological processes - liver diseases, heart failure - age - age - sex - sex - body temperature - body temperature - genetic factors - polymorhism - genetic factors - polymorhism - drug interactions enzyme inhibition, enzyme induction - drug interactions enzyme inhibition, enzyme induction

Drug interactions - enzyme induction Drug induction Drug induction increase of enzyme activity can decrease drug potency, increase of enzyme activity can decrease drug potency, - result is an increased synthesis of microsomal enzymes after repeated use of drugs - generally, metabolism of inducers itself is increased as well as various other compounds, - increase of metabolism may increase toxicity of paracetamol – toxic metabolites - increase of metabolism may increase toxicity of paracetamol – toxic metabolites Drugs that cause induction barbiturates, carbamazepine, ethanol (chronic use), glutethimide, griseofulvin, meprobamate, phenytoin, rifampicin, sulphinpyrazone,

Drug interactions - enzyme inhibition Drug inhibition Drug inhibition - enzyme inhibition can slow down the metabolism - enzyme inhibition can slow down the metabolism - action of coadministrated drug may be increased and prolonged - action of coadministrated drug may be increased and prolonged Drugs that cause inhibition - cimetidine, - erythromycin, - quinolone - sodium valproat, - allopurinol

Genetic polymorphism

1. Plymorphism in acetylation (rapid or slow acetylators – isoniasid (INH), hydralazine and procainamide, sulphasalazine 1. Plymorphism in acetylation (rapid or slow acetylators – isoniasid (INH), hydralazine and procainamide, sulphasalazine 2. Poor oxidisers – debrisoquine, metoprolol, timolol, haloperidol 3. Glucose-6-phosphate dehydrogenase deficiency G-6-PD – risk of haemolysis – aspirin, probenecid, quinine, chloroquine, nitrofurantoin, some sulphonamides 4. Pseudocholinesterase deficiency – malignant hyperthermia – suxametonium,

CYP 2D6

Drug excretion

- Drugs are exreted : either unchanged or as metabolites. - Lipid-soluble drugs are not readily eliminated until they are metabolized to more polar compounds Drug excretion Drug excretion

Renal excretion Extrarenal excretion

Renal excretion 1. Glomerular filtration - passive Depends on: fractional plasma protein binding glomerular filtration rate (size of molecules) glomerular filtration rate (size of molecules) (MW ) is completely held back (MW ) is completely held back by this way is removed about 20% of drugs from the blood by this way is removed about 20% of drugs from the blood 2. Passive tubular reabsorption  the nonionized forms of weak acids and bases undergo passive reabsorption.  the nonionized forms of weak acids and bases undergo passive reabsorption.  The concentration gradient for back-diffusion is created by the reabsorption of water with Na+ and other inorganic ions.  The concentration gradient for back-diffusion is created by the reabsorption of water with Na+ and other inorganic ions.

When the tubular urine is made more acidic, the excretion of weak acids is reduced (alkalinization of the urine have the opposite effects on the excretion of weak bases). When the tubular urine is made more acidic, the excretion of weak acids is reduced (alkalinization of the urine have the opposite effects on the excretion of weak bases). Treatment of drug poisoning, the excretion of some drugs can be hastened by appropriate alkalinization or acidification of the urine. Treatment of drug poisoning, the excretion of some drugs can be hastened by appropriate alkalinization or acidification of the urine.

Renal excretion (cont.) 3. Active tubular secretion  Many organic acids (such as penicillin) and metabolites (such as glucuronides) are transported by the system that secretes naturally occurring substances (such as uric acid).  Many organic acids (such as penicillin) and metabolites (such as glucuronides) are transported by the system that secretes naturally occurring substances (such as uric acid).  Organic bases, such as tetraethylammonium, are transported by a separate system that secretes choline, histamine, and other endogenous bases.  The carrier systems are relatively nonselective, and organic ions of similar charge compete for transport.  The carrier systems are relatively nonselective, and organic ions of similar charge compete for transport.  Both transport systems also can be bidirectional, and at least some drugs are both secreted and actively reabsorbed. (an endogenous organic acid is uric acid).  Both transport systems also can be bidirectional, and at least some drugs are both secreted and actively reabsorbed. (an endogenous organic acid is uric acid).

Excretion by other routes Biliary and fecal excretion Biliary and fecal excretion Saliva, sweat, tears - the concentration of some drugs in saliva parallels that in plasma. Saliva, sweat, tears - the concentration of some drugs in saliva parallels that in plasma. Breast milk - excretion by breast milk is dependent mainly upon diffusion, Milk is more acidic than plasma, basic compounds may be slightly concentrated in this fluid. Breast milk - excretion by breast milk is dependent mainly upon diffusion, Milk is more acidic than plasma, basic compounds may be slightly concentrated in this fluid.

Excretion by Other Routes 1. Saliva 1. Saliva  Excretion of drugs into sweat, saliva, and tears is quantitatively unimportant.  Excretion by saliva is dependent mainly upon diffusion  Drugs excreted in the saliva enter the mouth, where they are usually swallowed.  The concentration of some drugs in saliva parallels that in plasma.  Saliva may therefore be a useful biological fluid in which to determine drug concentrations when it is difficult or inconvenient to obtain blood.

2. Breast milk 2. Breast milk  Excretion by breast milk is dependent mainly upon diffusion  Milk is more acidic than plasma, basic compounds may be slightly concentrated in this fluid,  Nonelectrolytes, such as ethanol and urea, readily enter breast milk and reach the same concentration as in plasma, independent of the pH of the milk.  Excretion of drugs in breast milk are potential sources of unwanted pharmacological effects in the nursing infant.

3. Feces 3. Feces Substances excreted in the feces are mainly unabsorbed orally ingested drugs or metabolites excreted in the bile and not reabsorbed from the intestinal tract. Substances excreted in the feces are mainly unabsorbed orally ingested drugs or metabolites excreted in the bile and not reabsorbed from the intestinal tract. 4. Biliary excretion 4. Biliary excretion

Elimination

Rate of elimination Elimination of most drugs from the body after therapeutically relevant doses follows first-order kinetics. To illustrate first order kinetics we might consider what would happen if we were to give a drug by i.v. bolus injection, collect blood samples at various times and measure the plasma concentrations of the drug. We might see a decrease in concentration as the drug is eliminated.

First-order kinetics Elimination half-life (t 1/2 ) Definition: Elimination half-life is the time it takes the drug concentration in the blood to decline to one half of its initial value. It is a secondary parameter : The elimination half-life is dependent on the ratio of V D and CL. Unit : time (min, h, day)

First order kinetics half - life  Most drugs exhibit first order kinetics – disappeaance of drug from plasma follows exponential patterns.  Most drugs exhibit first order kinetics – disappeaance of drug from plasma follows exponential patterns.  The rate of elimination is directly proportional to drug concentration.  The rate of elimination is directly proportional to drug concentration.  Plasma half-life is directly proportional to the volume of distribution and inversely proportional to the overall rate of clearance  Plasma half-life is directly proportional to the volume of distribution and inversely proportional to the overall rate of clearance  With repeated dosage or sustained delivery of a drug the plasma concentration approaches a steady state within 4-5 half-lifes.  With repeated dosage or sustained delivery of a drug the plasma concentration approaches a steady state within 4-5 half-lifes.

Rate of elimination Elimination which follows first-order kinetics: dC/dt = - k el. C k el …. rate constant of elimination rate of change is proportional to concentration and is therefore decreasing with time as the conc. decreases

Rate of elimination half-life : t 1/2 C= C 0 / 2 t= t 1/2 = ln2 / kel = 0.693/ kel after 4 half-lives: 6% remaining, 94% eliminated monoexponential decay: C(t) = C 0. e - kel. t

Saturation kinetics  In a few cases as ethanol, phynytoin and salicylate disapppearance of drug from plasma does not follow exponential patterns.  Pattern of desappearance of drug is linear – drug is removed at a constant rate that is indipendent of plasma concentration  This is often called zero order kinetics

Use of t 1/2 : 1/ t 1/2 can be used to predict how long it will take for the drug to be eliminated from plasma.